IntriCon Corp. (IIN) Upgraded to “Hold” at Zacks Investment Research
IntriCon Corp. (NASDAQ:IIN) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Wednesday.
According to Zacks, “IntriCon designs, develops, engineers and manufactures microminiaturized medical and electronic products. The Company supplies microminiaturized components, systems and molded plastic parts, primarily to the hearing instrument manufacturing industry, as well as the computer, government, electronics, telecommunications and medical equipment industries. The Company has facilities in the United States, Asia and Europe. “
IntriCon Corp. (NASDAQ:IIN) opened at 6.14 on Wednesday. The company’s market cap is $41.72 million. The company has a 50-day moving average of $4.91 and a 200-day moving average of $5.34. IntriCon Corp. has a 52 week low of $4.12 and a 52 week high of $8.65.
IntriCon Corp. (NASDAQ:IIN) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by $0.14. The company earned $17 million during the quarter, compared to the consensus estimate of $16.71 million. IntriCon Corp. had a positive return on equity of 2.36% and a negative net margin of 0.05%. On average, equities analysts expect that IntriCon Corp. will post ($0.10) EPS for the current year.
Several institutional investors have recently made changes to their positions in the stock. Bard Associates Inc. purchased a new position in shares of IntriCon Corp. during the second quarter valued at approximately $211,000. Coe Capital Management LLC purchased a new position in shares of IntriCon Corp. during the second quarter valued at approximately $240,000. AWM Investment Company Inc. purchased a new position in shares of IntriCon Corp. during the second quarter valued at approximately $294,000. Renaissance Technologies LLC raised its position in shares of IntriCon Corp. by 0.9% in the first quarter. Renaissance Technologies LLC now owns 171,500 shares of the company’s stock valued at $1,092,000 after buying an additional 1,500 shares in the last quarter. Finally, Heartland Advisors Inc. purchased a new position in shares of IntriCon Corp. during the second quarter valued at approximately $2,136,000. Hedge funds and other institutional investors own 23.33% of the company’s stock.
About IntriCon Corp.
IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.
Receive News & Stock Ratings for IntriCon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Corp. and related stocks with our FREE daily email newsletter.